GENE ONLINE|News &
Opinion
Blog

China NMPA
Trials & Approvals AstraZenecaEosinophilic Asthma
China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma
2024-08-21
Trials & Approvals Chronic Kidney Disease
AstraZeneca’s Treatment for Chronic Kidney Disease Wins Yet Another Approval
2022-09-05
PD-1 Inhibitor
Lepu, HanX Scores China Approval For PD-1 Inhibitor
2022-07-27
China BeiGene
BeiGene Granted NMPA Approval to Treat World’s Most Prevalent Esophageal Cancer
2022-04-20
China Cholesterol
Innovent’s PCSK-9 Antibody Meets Primary Endpoints in Two Phase 3 Studies
2022-02-18
China COVID-19
China Gives Conditional Approval to Pfizer’s Covid-19 Oral Antiviral
2022-02-14
China Autoimmune
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
China Rare Disease
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
China Multiple MyelomaChina NMPA
Antengene’s XPO1 Inhibitor Receives First-In-Class Approval in China for Multiple Myeloma
2021-12-20
China COVID-19
Brii Bio’s COVID-19 Antibody Cocktail Gets the Greenlight in China
2021-12-09
Trials & Approvals CAR T-cell Therapy
JW Therapeutics’ CAR-T Approval in China Comes On the Heels of its Rival
2021-09-08
Trials & Approvals Immunotherapy
Chinese Regulator Accepts BeiGene’s Tislelizumab sBLA for Nasopharyngeal Cancer
2021-08-23
Gilead’s Yescarta Becomes First CAR-T Therapy to Score Regulatory Approval in China
2021-06-27
Trials & Approvals PD-1 Inhibitor
Innovent, Lilly Bag Third Approval for PD-1 Inhibitor Tyvyt in China
2021-06-07
Trials & Approvals Heart Failure
Forxiga Gains Approval in China for Multiple Cardio-Related Diseases
2021-02-07
1 2 3
LATEST
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
Seasonal Skin Irritations Rise, Driving Demand for Accessible and Easy-to-Use Treatments
2025-05-14
Tirzepatide Users See 20.2% Average Weight Loss in Obesity Management Trial
2025-05-14
iMMagine-1 Phase 2 Study Provides Data on Investigational Matter Characteristics and Behavior
2025-05-14
READ MORE
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top